Cognitive Impairment in Patients With Breast Cancer: Understanding the Impact of Chemotherapy and Endocrine Therapy
- 6 March 2020
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 38 (17), 1871-1874
- https://doi.org/10.1200/jco.20.00336
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations.Brain Imaging and Behavior, 2013
- Cognitive Complaints After Breast Cancer Treatments: Examining the Relationship With Neuropsychological Test PerformanceJNCI Journal of the National Cancer Institute, 2013
- Is basic research providing answers if adjuvant anti-estrogen treatment of breast cancer can induce cognitive impairment?Life Sciences, 2013
- Estradiol synthesis within the human brainNeuroscience, 2011
- Self‐reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side‐studyPsycho‐Oncology, 2011
- Longitudinal Assessment of Cognitive Changes Associated With Adjuvant Treatment for Breast Cancer: Impact of Age and Cognitive ReserveJournal of Clinical Oncology, 2010
- Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast CancerJournal of Clinical Oncology, 2006
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- Neurocognitive Performance in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy and TamoxifenJournal of Clinical and Experimental Neuropsychology, 2004
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002